BeOne Medicines (ONC) Amortization - Intangibles (2017 - 2024)
BeOne Medicines (ONC) posted quarterly Amortization - Intangibles of $1.2 million for Q2 2024, up 14.49% year-over-year from $1.0 million in Q3 2023, and down 0.51% quarter-over-quarter from $1.2 million in Q1 2024.
Powered by 
Analysis
BeOne Medicines (ONC) Amortization - Intangibles (2017 - 2024) Analysis & Trends
BeOne Medicines (ONC) has reported Amortization - Intangibles for 8 consecutive years, with $1.2 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Amortization - Intangibles rose 14.49% year-over-year to $1.2 million; the TTM figure through Jun 2024 stood at $7.6 million (up 91.06% YoY), while the FY2023 annual figure was $7.2 million, up 82.07% from the prior year.
- Amortization - Intangibles retreated to $1.2 million in Q2 2024 per ONC's latest filing, from $1.2 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $3.0 million in Q4 2023 and bottomed at $187000.0 in Q3 2020.
- Historically, Amortization - Intangibles has averaged $896444.4 across 5 years, with a median of $977500.0 in 2022.
- Annual changes were most pronounced in 2020 — Amortization - Intangibles sank 43.5% — and 2022, when it jumped 442.55%.
- BeOne Medicines' Amortization - Intangibles stood at $188000.0 in 2020, then surged by 335.64% to $819000.0 in 2021, then gained by 18.32% to $969000.0 in 2022, then soared by 205.16% to $3.0 million in 2023, then slumped by 60.2% to $1.2 million in 2024.
- Business Quant data shows ONC's Amortization - Intangibles at $1.2 million in Q2 2024, $1.2 million in Q1 2024, and $3.0 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 986,000.00 |
| Dec 31, 2022 | 969,000.00 |
| Sep 30, 2022 | 987,000.00 |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 819,000.00 |
| Sep 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Mar 31, 2021 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Sep 30, 2020 | 187,000.00 |
| Jun 30, 2020 | 188,000.00 |
| Mar 31, 2020 | 283,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Sep 30, 2019 | 331,000.00 |